These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 36762399)
1. Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma. Wu H; Zhang J; Fu L; Wu R; Gu Z; Yin C; He K Technol Cancer Res Treat; 2023; 22():15330338221147772. PubMed ID: 36762399 [No Abstract] [Full Text] [Related]
2. Identification of a novel model based on ferroptosis-related genes for predicting the prognosis of diffuse large B-cell lymphomas. Wang J; Peng H; Zhang G; Yan W Hematology; 2023 Dec; 28(1):2198862. PubMed ID: 37199349 [TBL] [Abstract][Full Text] [Related]
3. Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma. Li W; Yao R; Yu N; Zhang W Cancer Biomark; 2024; 40(1):125-139. PubMed ID: 38517778 [TBL] [Abstract][Full Text] [Related]
4. Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell Lymphoma. Chen H; He Y; Pan T; Zeng R; Li Y; Chen S; Li Y; Xiao L; Zhou H Pharmgenomics Pers Med; 2021; 14():609-619. PubMed ID: 34079336 [TBL] [Abstract][Full Text] [Related]
5. Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell Lymphoma. Weng J; Chen L; Liu H; Yang XP; Huang L Inflammation; 2022 Jun; 45(3):1146-1161. PubMed ID: 35064379 [TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration. Chen X; Hu S; Han Y; Cai Y; Lu T; Hu X; Chu Y; Zhou X; Wang X Clin Exp Med; 2023 Oct; 23(6):2601-2617. PubMed ID: 36682001 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma. Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X Front Immunol; 2023; 14():1277695. PubMed ID: 38155967 [TBL] [Abstract][Full Text] [Related]
8. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma. Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients. Liu G; Ma JY; Hu G; Jin H PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149 [TBL] [Abstract][Full Text] [Related]
11. A novel NET-related gene signature for predicting DLBCL prognosis. Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma. Li Y; Liu X; Chang Y; Fan B; Shangguan C; Chen H; Zhang L Biomed Res Int; 2022; 2022():2645090. PubMed ID: 36281462 [TBL] [Abstract][Full Text] [Related]
13. Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma. Xiong D; Wei X; Huang W; Zheng J; Feng R Aging (Albany NY); 2024 Jan; 16(2):1049-1076. PubMed ID: 38240686 [TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration. Xiong D; Li M; Zeng C Transl Oncol; 2022 Feb; 16():101314. PubMed ID: 34920339 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma. Liu C; Liu L Front Genet; 2022; 13():1037716. PubMed ID: 36313435 [No Abstract] [Full Text] [Related]
16. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826 [TBL] [Abstract][Full Text] [Related]
17. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885 [TBL] [Abstract][Full Text] [Related]
18. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048 [TBL] [Abstract][Full Text] [Related]
19. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer. Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228 [No Abstract] [Full Text] [Related]
20. Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma. Zhang B; Zhang T; Zheng Z; Lin Z; Wang Q; Zheng D; Chen Z; Ma Y Front Oncol; 2022; 12():1020566. PubMed ID: 36713586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]